Transport Trafficking Antibodies

Transport and trafficking antibodies are specialized immunological tools designed to target and bind specific proteins involved in the intracellular transport and trafficking of molecules. These antibodies are crucial for studying the mechanisms of protein, lipid, and vesicle movement within cells, encompassing processes such as endocytosis, exocytosis, and autophagy. They enable the detailed analysis of various cellular pathways and contribute to a better understanding of the dynamics of intracellular transport.

Content: Transport and trafficking antibodies recognize and bind to a range of target proteins, including transporters, channels, vesicle-associated proteins, and motor proteins. Key targets often include proteins such as Rab GTPases, clathrin, dynamin, SNAREs (Soluble NSF Attachment Protein Receptors), and motor proteins like dynein and kinesin. These antibodies can be monoclonal or polyclonal, each having specific applications based on the required specificity and binding affinity.

Applications: Transport and trafficking antibodies are utilized in several advanced research applications, including:

• Immunofluorescence (IF): To visualize the localization and movement of transport proteins and vesicles within live or fixed cells.
• Western Blotting (WB): To detect and quantify the expression levels of specific transport and trafficking proteins under various experimental conditions.
• Co-immunoprecipitation (Co-IP): To study protein-protein interactions within the cellular transport and trafficking pathways, such as interactions between Rab proteins and their effectors.
• Flow Cytometry: To assess the expression and internalization of membrane proteins by detecting surface-bound or intracellularly trafficked proteins.
• ELISA: To quantify the levels of trafficking-related proteins in cell lysates, tissues, or biofluids.

These antibodies are integral to the study of intracellular trafficking, providing insights into cellular functions, signaling pathways, and disease mechanisms, including neurodegenerative disorders, cancer, and infectious diseases.